Breast Cancer Program
Dana Farber/Harvard Cancer Center Breast Cancer Advocates
The Breast Cancer Advocacy Group (BCAG) contributes an informed patient voice to breast cancer research. The advocates collaborate with breast cancer investigators within and beyond DF/HCC in planning and reviewing translational and clinical research in all its stages, with the goal of finding better treatments, improving patient outcomes, and ultimately preventing breast cancer.
Scientists and researchers frequently invite feedback and guidance from advocates on the direction of their research and its value to patients. In addition, the advocates focus on topics directly affecting the patient experience, such as tissue banking, consenting for clinical trials, suggesting outcome measures that are important to patients, identifying gaps in research, and patient education.
Advocates aspire to influence the nature of research questions to more closely reflect patient concerns, and to help bring treatments from the lab to the clinic efficiently and safely.